Solvay Pharma Gmbh is part of the international Solvay Group conducting business in the areas of pharmaceuticals, chemicals and plastics. Carrying responsibility for the international research and development of pharmaceuticals for the Solvay Goup, Solvay Pharmaceuticals has six core research indications; cardiovascular, gastro-intestinal, hormones, influenza and Parkinson's disease.

Cardiovascular

Focusing on the prevention and treatment of cardiovascular disease, Solvay Pharma develops therapeutics based in the anti-art class of hypertensive drugs. Solvay also produces a range of innovative products for emergency medicine.

Gastrointestinal

With a strong foothold in the gastrointestinal therapeutic area, Solvay Pharma has becomes the leading producer of lactulose through its prescription product Bifiteral ®. The company also has extensive experience, over 100 years in the research and development of enzyme preparations and produces Kreon ® for the treatment of cystic fibrosis.

Hormone preparations

Solvay offers a number of products for both testosterone replacement therapy in males and estrogen preparations for menopausal females.

Flu prevention

Solvay develops a unique pre-filled vaccine syringe for flu preventions in infants, children and adults.

Parkinson's disease

Treating patients with advanced Parkinson's disease, Solvay Pharma's Duodopa is a treatment system administered to patients according to the severity of their disease, offering an alternative to some traditional oral therapies.

Ideally looking for partners based in the US and Europe who have marketed products ready to out-license for the emerging market countries.